Curanex Pharmaceuticals CURX Ratios (2024-2026)

NASDAQ CURX
$4.97 -0.06 (-1.29%)
As of: Sep 29, 2026 · 3:50 PM EDT
Reported Financials

Curanex Pharmaceuticals Quarterly Ratios

Periods 5 quarters
Latest Jun 2026

Curanex Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2024 Jun2025 Sep2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 0.65M7.63M13.03M8.33M
Equity AverageEquity Avg. 0.56M0.40M7.30M12.76M8.00M
Invested CapitalInvested Cap. 0.71M
Leverage & Solvency
Interest Coverage RatioInterest Cover -18.65-232.60
Debt Ratio 0.51
Times Interest Earned -18.65-232.60
Valuation
Price to BookP/B 1.430.841.57
Enterprise Value 14.57M4.41M4.58M
Market Capitalization 20.41M9.38M7.52M
Return Ratios
Return on Capital Employed [ROCE]ROCE -16.78%-32.96%-90.33%
Return on Assets [ROA]ROA -16.47%-32.67%-89.28%
Return on Equity [ROE]ROE -17.22%-33.37%-92.89%

Curanex Pharmaceuticals Ratios API

Pull Curanex Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CURX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY